BioGaia New Sciences AB
Clinical trials sponsored by BioGaia New Sciences AB, explained in plain language.
Now part of
BioGaia AB
BIOG-B
NASDAQ STOCKHOLM
A biotech company developing probiotics for health.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.